Novartis Canada Receives Health Canada Approval For VANRAFIA For Proteinuria Reduction In Adults With Primary IgAN
NVS•Health Canada approval for VANRAFIA
-
Novartis Canada receives Health Canada approval for VANRAFIA for proteinuria reduction in adults with primary immunoglobulin A nephropathy.
-
July 13 (Reuters) - NOVARTIS CANADA:
Related News
Albertsons accused of overworking pharmacists, fueling opioid crisis as Washington state trial begins
ACI•
Rocky Mountain Chocolate Factory interim CEO Allen Harper files initial beneficial ownership statement
RMCF•
